We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+25.16%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.46B
AUM Growth
+$147M
Cap. Flow
-$82.7M
Cap. Flow %
-5.66%
Top 10 Hldgs %
25.13%
Holding
215
New
28
Increased
57
Reduced
41
Closed
25

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$31.1M
2
MRK icon
Merck
MRK
+$27.8M
3
MIRM icon
Mirum Pharmaceuticals
MIRM
+$24.3M
4
IMGN
Immunogen Inc
IMGN
+$14.5M
5
XENE icon
Xenon Pharmaceuticals
XENE
+$14.1M

Top Sells

Rank Stock Value
1
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$29.3M
2
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$28.4M
3
UTHR icon
United Therapeutics
UTHR
+$26.8M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$25.8M
5
PODD icon
Insulet
PODD
+$23.6M

Sector Composition

Rank Sector Weight
1 Healthcare 53.92%
2 Technology 13.34%
3 Industrials 8.74%
4 Consumer Discretionary 4.85%
5 Energy 4.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UBER icon
101
Uber
UBER
$153B
$2.67M 0.18%
61,897
– –
KLAC icon
102
KLA
KLAC
$259B
$2.61M 0.18%
53,890
– –
ACM icon
103
Aecom
ACM
$9.75B
$2.51M 0.17%
29,631
+7,178
+32% +$589K
NOW icon
104
ServiceNow
NOW
$129B
$2.4M 0.16%
21,375
– –
TXRH icon
105
Texas Roadhouse
TXRH
$13.7B
$2.38M 0.16%
21,214
-5,274
-20% -$580K
SHOP icon
106
Shopify
SHOP
$195B
$2.33M 0.16%
36,085
+28,471
+374% +$1.61M
AMZN icon
107
Amazon
AMZN
$2.96T
$2.32M 0.16%
17,786
+3,014
+20% +$344K
KRNT icon
108
Kornit Digital
KRNT
$791M
$2.24M 0.15%
76,379
-113,592
-60% -$2.57M
TSM icon
109
TSMC
TSM
$2.18T
$2.2M 0.15%
21,841
– –
HCCI
110
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$2.19M 0.15%
57,860
+4,476
+8% +$157K
SNOW icon
111
Snowflake
SNOW
$115B
$2.15M 0.15%
12,216
– –
ESTC icon
112
Elastic
ESTC
$7.81B
$2.15M 0.15%
33,515
-42,148
-56% -$2.64M
WCN
113
Waste Connections
WCN
$42B
$2.12M 0.15%
14,858
-28,630
-66% -$3.99M
ONTO icon
114
Onto Innovation
ONTO
$15.3B
$2.11M 0.14%
+18,108
New +$1.73M
COP icon
115
ConocoPhillips
COP
$141B
$2.07M 0.14%
20,000
– –
DALS
116
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
$2.05M 0.14%
200,000
– –
KRUS icon
117
Kura Sushi USA
KRUS
$593M
$1.96M 0.13%
+21,111
New +$1.56M
GOOG icon
118
Alphabet (Google) Class C
GOOG
$4.32T
$1.87M 0.13%
15,479
+787
+5% +$91.1K
STKL
119
DELISTED
SunOpta
STKL
$1.85M 0.13%
+275,956
New +$2.08M
SPRY icon
120
ARS Pharmaceuticals
SPRY
$612M
$1.84M 0.13%
275,000
-480,622
-64% -$3.21M
MDB icon
121
MongoDB
MDB
$32.1B
$1.75M 0.12%
4,252
+762
+22% +$222K
CRM icon
122
Salesforce
CRM
$158B
$1.68M 0.12%
7,963
+977
+14% +$199K
TJX icon
123
TJX Companies
TJX
$178B
$1.54M 0.11%
18,104
– –
WIX icon
124
WIX.com
WIX
$2.52B
$1.52M 0.1%
19,440
-8,327
-30% -$685K
FDX icon
125
FedEx
FDX
$75.4B
$1.52M 0.1%
+6,126
New +$1.4M
3 4
5
6 7

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Nicholas Investment Partners held 215 positions worth $1.46B, up 11% from $1.32B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Nicholas Investment Partners withdrew a net $82.7M in Q2 2023, closing 25 positions and reducing 41 holdings. Its most notable exit was Prometheus Biosciences, Inc. Common Stock, an estimated $29.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, up from 53% a quarter earlier, followed by Technology and Industrials.

Against the trend, Nicholas Investment Partners opened a new position in Intra-Cellular Therapies Inc. worth $31.6M.

  • Nicholas Investment Partners's largest Q2 2023 buy was Intra-Cellular Therapies Inc.: 499,503 shares worth $31.6M.
  • Nicholas Investment Partners added most to Xenon Pharmaceuticals in Q2 2023, an estimated $14.1M increase.
  • Nicholas Investment Partners's biggest Q2 2023 reduction was Lantheus, cutting an estimated $9.72M.
  • Nicholas Investment Partners fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $29.3M.
  • Nicholas Investment Partners's ten largest holdings make up 25% of its $1.46B portfolio in Q2 2023.
  • Nicholas Investment Partners opened 28 new positions and closed 25 in Q2 2023.
  • Nicholas Investment Partners's portfolio value rose 11% quarter-over-quarter to $1.46B.

Based on Nicholas Investment Partners's 13F filing for Q2 2023, filed 10 Aug 2023.